Navigation Links
New Study Provides Key Findings for Biopharma Product Launch Evaluation

CHAPEL HILL, N.C., Nov. 5 /PRNewswire/ -- As biopharmaceutical companies continue to bring new therapies to market, considerable efforts are placed on strategy and execution from development through launch, while post-launch evaluations largely focus on revenue growth and little else. In a continuing effort to support product launch excellence, a recent study was conducted by Best Practices, LLC reviewing launch evaluation with insights available in the newly published report, "Pharmaceutical Product Launch Evaluation Excellence: Processes & Measures to Evaluate Launch Success." This research initiative explored excellence in launch evaluation yielding key findings into continuous improvement strategies, plans and practices for both current and future landscapes across the biopharmaceutical industry.

To view the study abstract or complimentary summary of the full report "Pharmaceutical Product Launch Evaluation Excellence: Processes & Measures to Evaluate Launch Success," click on the following link

In a benchmarking study that included such influential companies as Abbott, GlaxoSmithKline, Novo Nordisk, Roche, and Sanofi-Aventis, many key topics were covered, including:
-- Understand Product Launch Evaluation Process

-- Determine Role of Forecasting in Evaluating Success

-- Identify Key Performance Measures Used

-- Review Importance of Specific Launch Evaluation Performance Measures

-- Describe Process and Timetable for Recalibration of Launch Targets

For more information on this report, contact Robert Naylor at or (919) 767-9244. To access the full report or download a complimentary copy of the report summary, go to


Best Pr

SOURCE Best Practices, LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Top-Line Preliminary Data From Phase II/III Study of Cortheras Relaxin in Acute Heart Failure to be Presented in Satellite Symposium at AHA Scientific Sessions 2008
2. DermTech and Rady Childrens Hospital-San Diego, Initiate Study to Understand Effects of Vitamin D as a Treatment for Atopic Dermatitis in Children and Young Adults
3. One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study
4. Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infections Presented at ICAAC / IDSA
5. BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza
6. Large-scale genetic study sheds new light on lung cancer
7. PARI Respiratory to Present New Study Comparing Nebulizers Delivering Budesonide at CHEST 2008
8. Independent Study Reveals SYNVISC(R) Offers Longer Knee Pain Relief and Greater Patient Satisfaction for Those Suffering from Osteoarthritis of the Knee
9. Clinical Study of Intermezzo(R) for the Treatment of Middle of the Night Awakening Published in SLEEP
10. Glycotex Reports First Patient Enrollment in Phase IIb Study of Lead Product Candidate GLYC-101 for Wound Healing
11. eRT Completes Milestone 100th Thorough QT Study
Post Your Comments:
(Date:10/8/2015)... Oct. 8, 2015  ATCC, the premier global biological ... has been selected by The Michael J. Fox Foundation ... to academic, pharmaceutical, and biotechnology organizations committed to speed ... the United States , and more than 5 ... the United States , and more than 5 ...
(Date:10/8/2015)... Maryland , October 8, 2015 ... .   --> Goldman Small ... in the small cap and microcap sectors, announced ... research report on PharmaCyte Biotech, Inc. (OTCQB - ... focused on developing and preparing treatments for cancer ...
(Date:10/8/2015)... WILMINGTON, Del. , Oct. 8, 2015 /PRNewswire/ ... of CRISPR-Cas technologies for genome editing, jointly announced ... DuPont and Caribou have cross-licensed their respective patent portfolios, ... CRISPR-Cas technology applications in major row crops, and ... applications. --> ...
(Date:10/8/2015)... , Oct. 8, 2015  Today the Wyss Institute ... launch of its start-up company Opsonix Inc. ... Harvard,s Office of Technology Development (OTD) and ... sepsis therapy for clinical use. ... least a million people every year in the U.S. ...
Breaking Biology Technology:
... Corp.,(Nasdaq: GENZ ) today announced that the ... for Renvela(TM) (sevelamer carbonate) for,the control of serum ... Renvela is a next-generation version of Renagel(R) (sevelamer,hydrochloride), ... "Since its approval in 1998, Renagel has ...
... Capital Holdings Asia and,its co-investors today announced that ... Corporation, the world,s largest privately held,crop- protection and ... 250 billion (US$2.2 billion). The sale will culminate ... market private,equity firm with investment teams in Japan, ...
... Oct. 22 AMDL, Inc. (Amex:,ADL), headquartered ... and Jilin, China, through its wholly owned ... biopharma company that,engages in the development, manufacture ... AMDL announced today that its,management will present ...
Cached Biology Technology:
(Date:10/2/2015)... , Oct. 02 2015 ... the "Enforcing the Law Using Biometrics" ... ) has announced the addition of the ... their offering. --> Research and Markets ... the "Enforcing the Law Using Biometrics" ...
(Date:9/30/2015)... , Sept. 30, 2015  The U.S. Court of ... another key ruling in favor of Crossmatch ™, ... fingerprint scanner company Suprema and its U.S. partner Mentalix ... a trade provision that declares it unlawful to engage ... infringing two of Crossmatch,s patents, the 5,900,993 patent and ...
(Date:9/29/2015)... is excited to be named one of the first 100 ... announcement was recently made at an invite-only IBM Watson: ... Francisco , where iDAvatars presented a demo of its ... "It is both an honor and a privilege to be ... the cognitive power of IBM Watson in our product, which ...
Breaking Biology News(10 mins):
... Energy (DOE),s Joint BioEnergy Institute (JBEI) have identified a potential ... diesel engines but would be clean, green, renewable and produced ... a JBEI research team engineered strains of two microbes, a ... a member of the terpene class of chemical compounds that ...
... Clemson University researchers recently reported finding a new class ... how cells repair damaged DNA. The finding from Cao,s ... with computational chemist Brian Dominy appeared in the Sept. ... "A new family of deamination repair enzymes in ...
... Five new research projects announced today (27 September) by ... to overcome some of the fundamental limitations of photosynthesis ... the sun. This research could lead to major increases ... of renewable chemicals. Just over 2M has been ...
Cached Biology News:
Bovine Coronary Artery Smooth Muscle Cells (BCASMC) (>500,000 cells)...
RECK (F-20)...
The improved design and new mechanical solutions of Finnpipette Focus Multichannel Plus improves accuracy and precision.In these low volume multichannel pipettes, the super blow-out function ensures ...
NAK/TBK1 (CT) Affinity Purified Polyclonal Antibody...
Biology Products: